Evidence map›Paper›PMID 21045080›Full record

ArticleGenome research2010

Gene expression profiling of human breast tissue samples using SAGE-Seq.

Zhenhua Jeremy Wu, Clifford A Meyer, Sibgat Choudhury, Michail Shipitsin, Reo Maruyama, Marina Bessarabova, Tatiana Nikolskaya, Saraswati Sukumar, Armin Schwartzman, Jun S Liu and 2 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Genome research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Diversity of Gene Expression in Hepatocellular Carcinoma Cells.Genomics, proteomics & bioinformatics · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Deconvoluting complex tissues for expression quantitative trait locus-based analyses.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Zhenhua Jeremy WuDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Clifford A Meyer
Sibgat Choudhury
Michail Shipitsin
Reo Maruyama
Marina Bessarabova
Tatiana Nikolskaya
Saraswati Sukumar
Armin Schwartzman
Jun S Liu
Kornelia Polyak
X Shirley Liu
Harvard University · USBrigham and Women's Hospital · USVavilov Institute of General Genetics · RU

Funding

Variation in Receptor Tyrosine Kinases and Breast Cancer RiskP50CA089393 · NCI · DANA-FARBER CANCER INSTITUTE · PI HARRIS, LYNDSAY NORINE · 2000 to 2009
$28.8M
Computational Models for Mechanisms of Global Transcription RegulationR01HG004069 · NHGRI · DANA-FARBER CANCER INST · PI LIU, XIAOLE SHIRLEY · 2006 to 2013
$3.6M
Epithelial-stromal cell interactions in breast cancerR01CA116235 · NCI · DANA-FARBER CANCER INST · PI POLYAK, KORNELIA · 2006 to 2010
$1.8M
NCI NIH HHS P50 CA089393NCI NIH HHS P50 CA89393NCI NIH HHS R01 CA116235NCI NIH HHS R01 CA116235-04S1NHGRI NIH HHS R01 1HG004069NHGRI NIH HHS R01 HG004069
6 · The paper itself

Abstract

We present a powerful application of ultra high-throughput sequencing, SAGE-Seq, for the accurate quantification of normal and neoplastic mammary epithelial cell transcriptomes. We develop data analysis pipelines that allow the mapping of sense and antisense strands of mitochondrial and RefSeq genes, the normalization between libraries, and the identification of differentially expressed genes. We find that the diversity of cancer transcriptomes is significantly higher than that of normal cells. Our analysis indicates that transcript discovery plateaus at 10 million reads/sample, and suggests a minimum desired sequencing depth around five million reads. Comparison of SAGE-Seq and traditional SAGE on normal and cancerous breast tissues reveals higher sensitivity of SAGE-Seq to detect less-abundant genes, including those encoding for known breast cancer-related transcription factors and G protein-coupled receptors (GPCRs). SAGE-Seq is able to identify genes and pathways abnormally activated in breast cancer that traditional SAGE failed to call. SAGE-Seq is a powerful method for the identification of biomarkers and therapeutic targets in human disease.

Indexed as

Analysis of VarianceBase SequenceBayes TheoremBreastBreast NeoplasmsEpithelial CellsFemaleGene Expression ProfilingGene LibraryHumansMolecular Sequence DataSensitivity and SpecificitySequence Analysis, DNA

Identifiers

PMID21045080
PMCPMC2989999
OpenAlexW2139639047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.